Ralph Niven's Net Worth

$1.12 Million

Estimate Recalculated Sep 8, 2024 07:17PM EST

Who is Ralph Niven?

Ralph Niven has an estimated net worth of $1.12 Million. This is based on reported shares across multiple companies, which include Aerovate Therapeutics, Inc., and DISCOVERY LABORATORIES INC /DE/.

SEC CIK

Ralph Niven's CIK is 0001168060

Past Insider Trading and Trends

2023 was Ralph Niven's most active year for acquiring shares with 19 total transactions. Ralph Niven's most active month to acquire stocks was the month of April. 2023 was Ralph Niven's most active year for disposing of shares, totalling 58 transactions. Ralph Niven's most active month to dispose stocks was the month of April. 2005 saw Ralph Niven paying a total of $408,157.68 for 141,263 shares, this is the most they've acquired in one year. In 2023 Ralph Niven cashed out on 68,300 shares for a total of $612,841.71, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Aerovate Therapeutics, Inc. (AVTE) Snapshot price: $1.9

CHIEF SCIENTIFIC OFFICER

Ralph Niven owns 1,609 units of Common Stock which is worth $3,057.10. From 2021 to 2024 Ralph Niven acquired a total of 54,600 shares in Aerovate Therapeutics, Inc. at a cost of $110,364.00, Ralph also disposed a total of 54,600 shares of Aerovate Therapeutics, Inc. equalling to $989,369.05.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$9.74
-$70,965.30
1.61K
Scheduled
Feb 5
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
$10.59
-$78,831.82
1.61K
Scheduled
Jan 5
Form 4
—
0
$9.16
-$65,711.64
1.61K
Scheduled
Dec 5
Form 4
—
0
$8.51
-$179,148.00
1.61K
Scheduled
Nov 22
Form 4
—
0
$9.66
-$34,359.87
1.61K
Jul 5
Form 4
—
0
$9.14
-$32,021.00
1.61K
Jun 5
Form 4
—
0
$11.45
-$42,401.82
1.61K
May 5
Form 4
—
0
$10.11
-$36,387.29
1.61K
Apr 5
Form 4
—
0
$12.89
-$48,884.62
1.61K
Scheduled
Mar 6
Form 4
—
0
$13.15
-$50,057.00
1.61K
Scheduled
Feb 6 - Feb 7
Form 4
—
0
$14.21
-$54,849.50
1.61K
Scheduled
Jan 5
Form 4
—
0
$9.70
-$34,559.00
1.61K
Scheduled
Dec 5
Form 4
—
0
$10.61
-$38,639.40
1.61K
Scheduled
Nov 7
Form 4
—
0
$8.89
-$30,891.59
1.61K
Scheduled
Oct 5
Form 4
—
0
$10.51
-$38,195.00
1.61K
Scheduled
Sep 6
Form 4
—
0
$11.60
-$43,102.25
1.61K
Scheduled
Aug 18
Form 4
—
0
—
—
0
Dec 14
Form 4
—
0
—
—
0
Apr 2 - Jun 29
Form 3
—
0
—
—
0
No matching records found

DISCOVERY LABORATORIES INC /DE/ (WINT) Snapshot price: $2.79

SVP-Preclinical Dev-Former

Ralph Niven owns 103,265 units of Common Stock which is worth $288,109.35.acquired a total of 158,140 shares in DISCOVERY LABORATORIES INC /DE/ at a cost of $444,831.57, Ralph also disposed a total of 56,875 shares of DISCOVERY LABORATORIES INC /DE/ equalling to $399,119.41.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+16.99%
15K
$3.36
$50,400.00
103.27K
Jun 1
Form 4
—
0
$6.21
-$21,911.25
88.27K
May 26
Form 4
—
0
$5.19
-$66,233.38
88.27K
May 24 - May 25
Form 4
—
0
$4.88
-$20,621.03
88.27K
May 23
Form 4
+870.16%
79.17K
$2.25
$177,892.45
88.27K
May 18
Form 4
+2.49%
221
$4.16
-$27,688.52
9.1K
Feb 15 - May 11
Form 4
-52.36%
-9.76K
$7.49
-$81,171.90
8.88K
Oct 22 - Dec 10
Form 4
+437.93%
15.17K
$1.81
$27,430.30
18.63K
Jun 8 - Aug 12
Form 4
+73.20%
1.46K
$5.20
$7,615.49
3.46K
Dec 2 - Apr 22
Form 4
—
0
—
—
0
Sep 12
Form 4
—
0
—
—
0
No matching records found